New Ulm Medical Center is a not-for-profit hospital and clinic serving the region in and around Brown County in south central Minnesota, United States. New Ulm Medical Center is part of the Allina Health System.

During the past decade, New Ulm Medical Center conducted 157 clinical trials. In the 10-year time frame, 157 clinical trials started and 107 clinical trials were completed, i.e. on average, 68.2% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 67 clinical trials were completed. i.e. 97.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Ulm Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 104 trials, followed by "SWOG Cancer Research Network" with 45 trials sponsored, "Alliance for Clinical Trials in Oncology" with 41 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "Eastern Cooperative Oncology Group" with 21 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Ulm Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 147 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "New Ulm Medical Center" are "Breast Cancer" (11 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials) and "Stage IV Lung Cancer AJCC v8" (9 trials). Many other conditions were trialed in "New Ulm Medical Center" in a lesser frequency.

Most popular intervention types in "New Ulm Medical Center" are "Drug" (194 trials), "Other" (153 trials), "Biological" (96 trials), "Procedure" (63 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (71 trials), "Quality-of-Life Assessment" (62 trials), "Questionnaire Administration" (43 trials), "Biospecimen Collection" (28 trials) and "Paclitaxel" (28 trials). Other intervention names were less common.

The vast majority of trials in "New Ulm Medical Center" are 201 trials for "All" genders, 46 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "New Ulm Medical Center". undefined are not yet recruiting, 61 are recruiting, 106 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in New Ulm Medical Center, 6 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in New Ulm Medical Center, 5 "Phase 1" clinical trials were conducted, 128 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".